These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 22185226)
1. "Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density". Piedra M; García-Unzueta MT; Berja A; Paule B; Lavín BA; Valero C; Riancho JA; Amado JA BMC Med Genet; 2011 Dec; 12():168. PubMed ID: 22185226 [TBL] [Abstract][Full Text] [Related]
2. RANKL and OPG gene polymorphisms: associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus. Bonfá AC; Seguro LP; Caparbo V; Bonfá E; Pereira RM Osteoporos Int; 2015 May; 26(5):1563-71. PubMed ID: 25609157 [TBL] [Abstract][Full Text] [Related]
3. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women. Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM Menopause; 2007; 14(5):913-8. PubMed ID: 17667143 [TBL] [Abstract][Full Text] [Related]
4. Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women. Shang M; Lin L; Cui H Clin Biochem; 2013 Oct; 46(15):1493-501. PubMed ID: 23531404 [TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphism of RANKL and OPG genes may play a role in bone and joint injury in rheumatoid arthritis. Xu S; Ma XX; Hu LW; Peng LP; Pan FM; Xu JH Clin Exp Rheumatol; 2014; 32(5):697-704. PubMed ID: 25068378 [TBL] [Abstract][Full Text] [Related]
6. Associations between OPG and RANKL polymorphisms, vertebral fractures, and abdominal aortic calcification in community-dwelling older subjects: the Sao Paulo Ageing & Health Study (SPAH). Pereira RMR; Figueiredo CP; Cha CC; Caparbo VF; Oliveira RM; Franco AS; Menezes PR; de Castro I; Onuchic LF Osteoporos Int; 2016 Nov; 27(11):3319-3329. PubMed ID: 27311721 [TBL] [Abstract][Full Text] [Related]
7. Association of OPG and RANKL gene polymorphisms with bone mineral density in Indian women. Nair S; Bhadricha H; Patil A; Surve S; Joshi B; Balasinor N; Desai M Gene; 2022 Oct; 840():146746. PubMed ID: 35868414 [TBL] [Abstract][Full Text] [Related]
8. Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men. Roshandel D; Holliday KL; Pye SR; Boonen S; Borghs H; Vanderschueren D; Huhtaniemi IT; Adams JE; Ward KA; Bartfai G; Casanueva F; Finn JD; Forti G; Giwercman A; Han TS; Kula K; Lean ME; Pendleton N; Punab M; Silman AJ; Wu FC; Thomson W; O'Neill TW; J Bone Miner Res; 2010 Aug; 25(8):1830-8. PubMed ID: 20205168 [TBL] [Abstract][Full Text] [Related]
10. Influence of polymorphisms in the RANKL/RANK/OPG signaling pathway on volumetric bone mineral density and bone geometry at the forearm in men. Roshandel D; Holliday KL; Pye SR; Ward KA; Boonen S; Vanderschueren D; Borghs H; Huhtaniemi IT; Adams JE; Bartfai G; Casanueva FF; Finn JD; Forti G; Giwercman A; Han TS; Kula K; Lean ME; Pendleton N; Punab M; Silman AJ; Wu FC; Thomson W; ONeill TW; Calcif Tissue Int; 2011 Dec; 89(6):446-55. PubMed ID: 21964949 [TBL] [Abstract][Full Text] [Related]
11. Association of Polymorphisms in RANK and RANKL Genes with Osteopenia in Arab Postmenopausal Women. Abdi S; Bukhari I; Ansari MGA; BinBaz RA; Mohammed AK; Hussain SD; Aljohani N; Al-Daghri NM Dis Markers; 2020; 2020():1285216. PubMed ID: 33376557 [TBL] [Abstract][Full Text] [Related]
12. Genetic variations in genes encoding RANK, RANKL, and OPG in rheumatoid arthritis: a case-control study. Assmann G; Koenig J; Pfreundschuh M; Epplen JT; Kekow J; Roemer K; Wieczorek S J Rheumatol; 2010 May; 37(5):900-4. PubMed ID: 20231205 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the influence of the T393C polymorphism of the GNAS gene on the clinical expression of primary hyperparathyroidism. Piedra M; Berja A; Ramos L; García-Unzueta MT; Morán JM; Ruiz D; Amado JA Endocrinol Diabetes Nutr; 2017 Dec; 64(10):524-530. PubMed ID: 29179855 [TBL] [Abstract][Full Text] [Related]
14. Gene-gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women. Zupan J; Mencej-Bedrac S; Jurković-Mlakar S; Prezelj J; Marc J J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):102-6. PubMed ID: 19896533 [TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphism of the OPG gene associated with breast cancer. Ney JT; Juhasz-Boess I; Gruenhage F; Graeber S; Bohle RM; Pfreundschuh M; Solomayer EF; Assmann G BMC Cancer; 2013 Jan; 13():40. PubMed ID: 23369128 [TBL] [Abstract][Full Text] [Related]
16. Relationship between the gene polymorphism of osteoprotegerin and bone mineral density in hemodialysis patients. Yin LL; Jing N; Zhao ZY; Liu XH; Du J; Qin LL; Song JG; Xu Y Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):37-41. PubMed ID: 28121359 [TBL] [Abstract][Full Text] [Related]
17. OPG, RANKL, and RANK gene polymorphisms and the bone mineral density response to alendronate therapy in postmenopausal Chinese women with osteoporosis or osteopenia. Zheng H; Wang C; He JW; Fu WZ; Zhang ZL Pharmacogenet Genomics; 2016 Jan; 26(1):12-9. PubMed ID: 26426211 [TBL] [Abstract][Full Text] [Related]
18. Rs219780 SNP of Claudin 14 Gene is not Related to Clinical Expression in Primary Hyperparathyroidism. Piedra M; Berja A; García-Unzueta MT; Ramos L; Valero C; Amado JA Clin Lab; 2015; 61(9):1197-203. PubMed ID: 26554238 [TBL] [Abstract][Full Text] [Related]
19. Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms. Eid R; Abdelsalam M; Fathy AA; Abolenein HM; Elmarghany EB; El-Hanafy AA; Hamdy N; Abd-Elmagid DS; Niazy NA; Abd-El Ghaffar DM Pediatr Rheumatol Online J; 2023 Jun; 21(1):58. PubMed ID: 37328895 [TBL] [Abstract][Full Text] [Related]
20. Osteoprotegerin, RANKL, and bone turnover in primary hyperparathyroidism: the effect of parathyroidectomy and treatment with alendronate. Szymczak J; Bohdanowicz-Pawlak A Horm Metab Res; 2013 Sep; 45(10):759-64. PubMed ID: 23888411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]